NewAmsterdam Pharma Company N.V.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $430.1M | — |
| Mar 2023 | — | $398.4M | — |
| Jun 2023 | — | $373.3M | — |
| Sep 2023 | — | $331.8M | — |
| Dec 2023 | — | $288.4M | $340.5M |
| Mar 2024 | — | $411.8M | — |
| Jun 2024 | — | $387.4M | — |
| Sep 2024 | — | $378.9M | $422.7M |
| Dec 2024 | — | $757.5M | $771.7M |
| Mar 2025 | — | $777.4M | $748.4M |
| Jun 2025 | — | $778.5M | $563.9M |
| Sep 2025 | — | $728.1M | $538.4M |
| Dec 2025 | — | $683.4M | $490.0M |
| Mar 2026 | — | $665.2M | $457.6M |
| Jun 2026 | — | $631.4M | $424.2M |